In vitro biocompatibility of 45S5 Bioglass®‐derived glass–ceramic scaffolds coated with poly(3‐hydroxybutyrate)

The aim of this work was to study the in vitro biocompatibility of glass–ceramic scaffolds based on 45S5 Bioglass®, using a human osteosarcoma cell line (HOS‐TE85). The highly porous scaffolds were produced by the foam replication technique. Two different types of scaffolds with different porosities were analysed. They were coated with a biodegradable polymer, poly(3‐hydroxybutyrate) (P(3HB)). The scaffold bioactivity was evaluated by soaking in a simulated body fluid (SBF) for different durations. Compression strength tests were performed before and after immersion in SBF. These experiments showed that the scaffolds are highly bioactive, as after a few days of immersion in SBF a hydroxyapatite‐like layer was formed on the scaffold's surface. It was also observed that P(3HB)‐coated samples exhibited higher values of compression strength than uncoated samples. Biocompatibility assessment was carried out by qualitative evaluation of cell morphology after different culture periods, using scanning electron microscopy, while cell proliferation was determined by using the AlamarBlue™ assay. Alkaline phosphatase (ALP) and osteocalcin (OC) assays were used as quantitative in vitro indicators of osteoblast function. Two different types of medium were used for ALP and OC tests: normal supplemented medium and osteogenic medium. HOS cells were seeded and cultured onto the scaffolds for up to 2 weeks. The AlamarBlue assay showed that cells were able to proliferate and grow on the scaffold surface. After 7 days in culture, the P(3HB)‐coated samples had a higher number of cells on their surfaces than the uncoated samples. Regarding ALP‐ and OC‐specific activity, no significant differences were found between samples with different pore sizes. All scaffolds containing osteogenic medium seemed to have a slightly higher level of ALP and OC concentration. These experiments confirmed that Bioglass®/P(3HB) scaffolds have potential as osteoconductive tissue engineering substrates for maintenance and normal functioning of bone tissue. Copyright © 2009 John Wiley & Sons, Ltd.

[1]  Oana Bretcanu,et al.  Polymer-bioceramic composites for tissue engineering scaffolds , 2008 .

[2]  Q. Chen,et al.  Bioglass-derived glass-ceramic scaffolds: study of cell proliferation and scaffold degradation in vitro. , 2008, Journal of biomedical materials research. Part A.

[3]  Enrica Verne,et al.  Biodegradable polymer coated 45S5 Bioglass®-derived glass-ceramic scaffolds for bone tissue engineering , 2007 .

[4]  Filippo Causa,et al.  Bioactive scaffolds for bone and ligament tissue , 2007, Expert review of medical devices.

[5]  X. Miao,et al.  Novel porous hydroxyapatite prepared by combining H2O2 foaming with PU sponge and modified with PLGA and bioactive glass. , 2007, Journal of biomaterials applications.

[6]  A. Boccaccini,et al.  Polyhydroxyalkanoate (PHA) biosynthesis from structurally unrelated carbon sources by a newly characterized Bacillus spp. , 2007, Journal of biotechnology.

[7]  Larry L. Hench,et al.  The story of Bioglass® , 2006, Journal of materials science. Materials in medicine.

[8]  A. Boccaccini,et al.  Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. , 2006, Biomaterials.

[9]  A. Boccaccini,et al.  Poly(D,L-lactic acid) coated 45S5 Bioglass-based scaffolds: processing and characterization. , 2006, Journal of biomedical materials research. Part A.

[10]  A. Boccaccini,et al.  Coupling Mechanical Competence and Bioresorbability in Bioglass®‐Derived Tissue Engineering Scaffolds , 2006 .

[11]  Aldo R Boccaccini,et al.  45S5 Bioglass-derived glass-ceramic scaffolds for bone tissue engineering. , 2006, Biomaterials.

[12]  D. Kaplan,et al.  Porosity of 3D biomaterial scaffolds and osteogenesis. , 2005, Biomaterials.

[13]  Aldo R Boccaccini,et al.  Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds. , 2004, Biomaterials.

[14]  L. Francis,et al.  Processing and properties of porous poly(L-lactide)/bioactive glass composites. , 2004, Biomaterials.

[15]  Jonathan C Knowles,et al.  Hydroxyapatite/poly(epsilon-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery. , 2004, Biomaterials.

[16]  R. Ritchie,et al.  Mechanistic fracture criteria for the failure of human cortical bone , 2003, Nature materials.

[17]  Larry L Hench,et al.  Third-Generation Biomedical Materials , 2002, Science.

[18]  Larry L. Hench,et al.  Bioglass ®45S5 Stimulates Osteoblast Turnover and Enhances Bone Formation In Vitro: Implications and Applications for Bone Tissue Engineering , 2000, Calcified Tissue International.

[19]  M. Gowen,et al.  Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype? , 1994, Bone.

[20]  W. Bonfield,et al.  In vitro and in vivo evaluation of polyhydroxybutyrate and of polyhydroxybutyrate reinforced with hydroxyapatite. , 1991, Biomaterials.

[21]  T Kitsugi,et al.  Ca,P-rich layer formed on high-strength bioactive glass-ceramic A-W. , 1990, Journal of biomedical materials research.

[22]  Laurent Chazeau,et al.  Toughening of bio-ceramics scaffolds by polymer coating , 2007 .

[23]  B D Boyan,et al.  Role of material surfaces in regulating bone and cartilage cell response. , 1996, Biomaterials.